Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Javelaud, K. Mohammad, C. McKenna, Pierrick Fournier, F. Luciani, M. Niewolna, J. André, V. Delmas, L. Larue, T. Guise, A. Mauviel (2007)
Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis.Cancer research, 67 5
G. Imokawa (2004)
Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders.Pigment cell research, 17 2
T. Luger, T. Schwarz (1990)
Evidence for an epidermal cytokine network.The Journal of investigative dermatology, 95 6 Suppl
M. Herlyn, U. Graeven, D. Speicher, B. Sela, J. Bennicelli, R. Kath, D. Guerry (1991)
Characterization of tenascin secreted by human melanoma cells.Cancer research, 51 18
P. Bornstein (1995)
Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1The Journal of Cell Biology, 130
J. Rangel, M. Nosrati, S. Torabian, L. Shaikh, S. Leong, C. Haqq, James Miller, Richard Sagebiel, M. Kashani-Sabet (2008)
Osteopontin as a molecular prognostic marker for melanomaCancer, 112
M. Fukunaga-Kalabis, G. Martinez, S. Telson, Zhao-Jun Liu, K. Balint, I. Juhász, D. Elder, B. Perbal, M. Herlyn (2008)
Downregulation of CCN3 expression as a potential mechanism for melanoma progressionOncogene, 27
H. Tuominen, M. Kallioinen (1994)
Increased tenascin expression in melanocytic tumorsJournal of Cutaneous Pathology, 21
N. Haass, K. Smalley, Ling Li, M. Herlyn (2005)
Adhesion, migration and communication in melanocytes and melanoma.Pigment cell research, 18 3
S. Nilsson, Hayley Johnston, G. Whitty, B. Williams, Ryan Webb, D. Denhardt, I. Bertoncello, L. Bendall, P. Simmons, D. Haylock (2005)
Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells.Blood, 106 4
N. Haass, K. Smalley, M. Herlyn (2003)
The Role of Altered Cell–Cell Communication in Melanoma ProgressionJournal of Molecular Histology, 35
K. Sakamoto, Shunji Yamaguchi, R. Ando, A. Miyawaki, Y. Kabasawa, M. Takagi, C. Li, B. Perbal, K. Katsube (2002)
The Nephroblastoma Overexpressed Gene (NOV/ccn3) Protein Associates with Notch1 Extracellular Domain and Inhibits Myoblast Differentiation via Notch Signaling Pathway*The Journal of Biological Chemistry, 277
A Gellhaus, X Dong, S Propson (2004)
Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cellsJ Biol Chem, 279
F. Bidard, J. Pierga, A. Vincent-Salomon, M. Poupon (2008)
A “class action” against the microenvironment: do cancer cells cooperate in metastasis?Cancer and Metastasis Reviews, 27
Daniela Massi, A. Franchi, L. Borgognoni, U. Reali, M. Santucci (1999)
Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas.Human pathology, 30 3
P. Bornstein, E. Sage (2002)
Matricellular proteins: extracellular modulators of cell function.Current opinion in cell biology, 14 5
H. Nemoto, S. Rittling, H. Yoshitake, K. Furuya, T. Amagasa, K. Tsuji, A. Nifuji, D. Denhardt, M. Noda (2001)
Osteopontin Deficiency Reduces Experimental Tumor Cell Metastasis to Bone and Soft TissuesJournal of Bone and Mineral Research, 16
D. Courter, L. Lomas, M. Scatena, C. Giachelli (2005)
Src kinase activity is required for integrin alphaVbeta3-mediated activation of nuclear factor-kappaB.The Journal of biological chemistry, 280 13
L. McCallum, S. Price, N. Planque, B. Perbal, A. Pierce, A. Whetton, A. Irvine (2006)
A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation.Blood, 108 5
M. Young, J. Kerr, J. Termine, U. Wewer, Mary Wang, O. McBride, L. Fisher (1990)
cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN).Genomics, 7 4
Y. Saitoh, J. Kuratsu, Hideo Takeshima, Shunsuke Yamamoto, Yukitaka Ushio (1995)
Expression of osteopontin in human glioma. Its correlation with the malignancy.Laboratory investigation; a journal of technical methods and pathology, 72 1
A. Bleau, N. Planque, N. Lazar, D. Zambelli, A. Ori, T. Quan, Gary Fisher, K. Scotlandi, B. Perbal (2007)
Antiproliferative activity of CCN3: Involvement of the C‐terminal module and post‐translational regulationJournal of Cellular Biochemistry, 101
Istvan Valyi-Nagy, G. Hirka, P. Jensen, I. Shih, István Juhász, M. Herlyn (1993)
Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact.Laboratory investigation; a journal of technical methods and pathology, 69 2
K. Galoian, N. Garamszegi, S. Garamszegi, S. Scully (2007)
Molecular Mechanism of Tenascin-C Action on Matrix Metalloproteinase-1 Invasive PotentialExperimental Biology and Medicine, 232
R. Kalluri, M. Zeisberg (2006)
Fibroblasts in cancerNature Reviews Cancer, 6
Hema Rangaswami, Anuradha Bulbule, G. Kundu (2004)
Nuclear Factor-inducing Kinase Plays a Crucial Role in Osteopontin-induced MAPK/IκBα Kinase-dependent Nuclear Factor κB-mediated Promatrix Metalloproteinase-9 Activation*Journal of Biological Chemistry, 279
R. Coffey, R. Derynck, Josiah Wilcox, T. Bringman, A. Goustin, H. Moses, M. Pittelkow (1987)
Production and auto-induction of transforming growth factor-α in human keratinocytesNature, 328
J. Murphy-Ullrich (2001)
The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?The Journal of clinical investigation, 107 7
X. Tong, J. O'kelly, D. Xie, A. Mori, N. Lemp, Robert Mckenna, C. Miller, H. Koeffler (2004)
Cyr61 suppresses the growth of non-small-cell lung cancer cells via the β-catenin–c-myc–p53 pathwayOncogene, 23
N. Planque, Chang Li, S. Saule, A. Bleau, B. Perbal (2006)
Nuclear addressing provides a clue for the transforming activity of amino‐truncated CCN3 proteinsJournal of Cellular Biochemistry, 99
H. Sage, M. Reed, S. Funk, T. Truong, Melissa Steadele, P. Puolakkainen, D. Maurice, J. Bassuk (2003)
Cleavage of the Matricellular Protein SPARC by Matrix Metalloproteinase 3 Produces Polypeptides That Influence Angiogenesis*Journal of Biological Chemistry, 278
M. Matic, W. Evans, P. Brink, M. Simon (2002)
Epidermal stem cells do not communicate through gap junctions.The Journal of investigative dermatology, 118 1
M. Manara, B. Perbal, S. Benini, R. Strammiello, V. Cerisano, S. Perdichizzi, M. Serra, A. Astolfi, F. Bertoni, J. Alami, H. Yeger, P. Picci, K. Scotlandi (2002)
The expression of ccn3(nov) gene in musculoskeletal tumors.The American journal of pathology, 160 3
P. Ongusaha, Jong‐il Kim, Li Fang, T. Wong, G. Yancopoulos, Stuart Aaronson, Sam Lee (2003)
p53 induction and activation of DDR1 kinase counteract p53‐mediated apoptosis and influence p53 regulation through a positive feedback loopThe EMBO Journal, 22
D. Brigstock (1999)
The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family.Endocrine reviews, 20 2
D. Denhardt (2005)
Osteopontin expression correlates with melanoma invasion.The Journal of investigative dermatology, 124 5
C. Denkert, A. Siegert, A. Leclere, A. Turzynski, S. Hauptmann (2004)
An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cellsClinical & Experimental Metastasis, 19
Paul Bornstein (2001)
Thrombospondins as matricellular modulators of cell function.The Journal of clinical investigation, 107 8
P. Wai, P. Kuo (2008)
Osteopontin: regulation in tumor metastasisCancer and Metastasis Reviews, 27
Chikako Hayashi, S. Rittling, T. Hayata, T. Amagasa, D. Denhardt, Y. Ezura, K. Nakashima, M. Noda (2007)
Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migrationJournal of Cellular Biochemistry, 101
R. Chiquet‐Ehrismann, Peter Kalla, C. Pearson, K. Beck, M. Chiquet (1988)
Tenascin interferes with fibronectin actionCell, 53
B. Perbal (2001)
NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issuesMolecular Pathology, 54
M. Fukunaga-Kalabis, G. Martinez, Zhao-Jun Liu, J. Kalabis, Paulus Mrass, W. Weninger, S. Firth, N. Planque, B. Perbal, M. Herlyn (2006)
CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1The Journal of Cell Biology, 175
A. Sonnenberg, K. Gehlsen, M. Aumailley, R. Timpl (1991)
Isolation of alpha 6 beta 1 integrins from platelets and adherent cells by affinity chromatography on mouse laminin fragment E8 and human laminin pepsin fragment.Experimental cell research, 197 2
D. Smit, B. Gardiner, R. Sturm (2007)
Osteonectin downregulates E‐cadherin, induces Osteopontin and Focal adhesion kinase activity stimulating an invasive melanoma phenotypeInternational Journal of Cancer, 121
V. Joliot, C. Martinerie, G. Dambrine, G. Plassiart, M. Brisac, J. Crochet, B. Perbal (1992)
Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomasMolecular and Cellular Biology, 12
O. Wever, M. Mareel (2002)
Role of Myofibroblasts at the Invasion Front, 383
A. Bradshaw, E. Sage (2001)
SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury.The Journal of clinical investigation, 107 9
M. Hsu, Wheelock Mj, Johnson Kr, M. Herlyn (1996)
Shifts in cadherin profiles between human normal melanocytes and melanomas.The journal of investigative dermatology. Symposium proceedings, 1 2
A. Gellhaus, Xuesen Dong, Sven Propson, Karen Maass, L. Klein-Hitpass, M. Kibschull, O. Traub, K. Willecke, B. Perbal, S. Lye, E. Winterhager (2004)
Connexin43 Interacts with NOVJournal of Biological Chemistry, 279
Linheng Li, W. Neaves (2006)
Normal stem cells and cancer stem cells: the niche matters.Cancer research, 66 9
O. Wever, M. Mareel (2003)
Role of tissue stroma in cancer cell invasionThe Journal of Pathology, 200
M. Hara, M. Yaar, A. Tang, M. Eller, W. Reenstra, Barbara Gilchrest (1994)
Role of integrins in melanocyte attachment and dendricity.Journal of cell science, 107 ( Pt 10)
Maryvonne Laurent, Cécile Martinerie, H. Thibout, M. Hoffman, Franck Verrecchia, Y. Bouc, A. Mauviel, H. Kleinman (2003)
NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR‐α‐dependent mechanismThe FASEB Journal, 17
J. Koblinski, Benjamin Kaplan-Singer, S. VanOsdol, Michael Wu, J. Engbring, Songlin Wang, C. Goldsmith, J. Piper, J. Vostal, J. Harms, D. Welch, H. Kleinman (2005)
Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.Cancer research, 65 16
C. Giachelli, Susan Steitz (2000)
Osteopontin: a versatile regulator of inflammation and biomineralization.Matrix biology : journal of the International Society for Matrix Biology, 19 7
D. Courter, L. Lomas, M. Scatena, C. Giachelli (2005)
Src Kinase Activity Is Required for Integrin αVβ3-Mediated Activation of Nuclear Factor-κB*Journal of Biological Chemistry, 280
Cristiane Lin, S. Leu, N. Chen, C. Tebeau, S. Lin, C. Yeung, L. Lau (2003)
CCN3 (NOV) Is a Novel Angiogenic Regulator of the CCN Protein Family*Journal of Biological Chemistry, 278
A. Sonnenberg, K. Gehlsen, M. Aumailley, R. Timpl (1991)
Isolation of α6β1 integrins from platelets and adherent cells by affinity chromatography on mouse laminin fragment E8 and human laminin pepsin fragmentExperimental Cell Research, 197
J. Homsi, C. Cubitt, A. Daud (2007)
The Src signaling pathway: a potential target in melanoma and other malignanciesExpert Opinion on Therapeutic Targets, 11
S. Philip, Anuradha Bulbule, Gopal Kundu (2001)
Osteopontin Stimulates Tumor Growth and Activation of Promatrix Metalloproteinase-2 through Nuclear Factor-κB-mediated Induction of Membrane Type 1 Matrix Metalloproteinase in Murine Melanoma Cells*The Journal of Biological Chemistry, 276
S. Kon, M. Maeda, T. Segawa, Y. Hagiwara, Y. Horikoshi, S. Chikuma, K. Tanaka, Mohammod Rashid, M. Inobe, A. Chambers, T. Uede (2000)
Antibodies to different peptides in osteopontin reveal complexities in the various secreted formsJournal of Cellular Biochemistry, 77
P. Framson, E. Sage (2004)
SPARC and tumor growth: Where the seed meets the soil?Journal of Cellular Biochemistry, 92
S. Tanimura, Keita Asato, Shuh-hei Fujishiro, M. Kohno (2003)
Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44.Biochemical and biophysical research communications, 304 4
W. Vogel (1999)
Discoidin domain receptors: structural relations and functional implicationsThe FASEB Journal, 13
(2005)
Ewing’s sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell
S. Alonso, L. Tracey, P. Ortiz, B. Pérez-Gómez, José Palacios, Marina Pollán, Juan Linares, Salvio Serrano, Ana Sáez-Castillo, Lydia Sánchez, R. Pajares, A. Sánchez-Aguilera, M. Artiga, M. Piris, J. Rodríguez-Peralto (2007)
A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.Cancer research, 67 7
I. Shih, David Elder, M. Hsu, M. Herlyn (1994)
Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes.The American journal of pathology, 145 4
F. Prada, L. Benedetti, A. Bravo, Mariano Alvarez, C. Carbone, O. Podhajcer (2007)
SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth.The Journal of investigative dermatology, 127 11
B. Perbal (2004)
CCN proteins: multifunctional signalling regulatorsThe Lancet, 363
Hema Rangaswami, Anuradha Bulbule, G. Kundu (2004)
Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.The Journal of biological chemistry, 279 37
H. Dvorak (1986)
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.The New England journal of medicine, 315 26
(2007)
SPARC endogenous level, rather than fibroblast-produced SPARC or 100 M. Fukunaga-Kalabis et al. stroma reorganization induced by SPARC, is responsible for melanoma cell growth
G. Robert, C. Gaggioli, Olivier Bailet, Carine Chavey, P. Abbe, E. Aberdam, Emilie Sabatié, A. Cano, A. Herreros, R. Ballotti, S. Tartare-Deckert (2006)
SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.Cancer research, 66 15
R. Coffey, R. Derynck, J. Wilcox, T. Bringman, A. Goustin, H. Moses, M. Pittelkow (1987)
Production and auto-induction of transforming growth factor-alpha in human keratinocytes.Nature, 328 6133
Leisl Packer, S. Pavey, A. Parker, M. Stark, P. Johansson, B. Clarke, P. Pollock, M. Ringnér, N. Hayward (2006)
Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN.Carcinogenesis, 27 9
Q. Yan, M. Weaver, N. Perdue, E. Sage (2005)
Matricellular protein SPARC is translocated to the nuclei of immortalized murine lens epithelial cellsJournal of Cellular Physiology, 203
Liubov Glukhova, Eric Angevin, Christian Lavialle, Bruno Cadot, M. Terrier-Lacombe, Bernard Perbal, Alain Bernheim, A. Goguel (2001)
Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas.Cancer genetics and cytogenetics, 130 2
(2007)
SPARC endogenous level, rather than fibroblast-produced SPARC or 100
R. Sturm, K. Satyamoorthy, F. Meier, B. Gardiner, D. Smit, B. Vaidya, M. Herlyn (2002)
Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells.Cancer research, 62 1
CT Fu, JF Bechberger, MA Ozog (2004)
CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppressionJ Biol Chem, 279
Mariano Alvarez, F. Prada, E. Salvatierra, Alicia, I., Bravo, V. Lutzky, C. Carbone, F. Pitossi, H., Eduardo Chuluyan, L. Osvaldo, Podhajcer (2005)
Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity.Cancer research, 65 12
E. Kääriäinen, P. Nummela, J. Soikkeli, M. Yin, M. Lukk, T. Jahkola, S. Virolainen, S. Virolainen, A. Ora, E. Ukkonen, O. Saksela, E. Hölttä (2006)
Switch to an invasive growth phase in melanoma is associated with tenascin‐C, fibronectin, and procollagen‐I forming specific channel structures for invasionThe Journal of Pathology, 210
S. Benini, B. Perbal, D. Zambelli, M. Colombo, M. Manara, M. Serra, M. Parenza, V. Martinez, P. Picci, K. Scotlandi (2005)
In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell typeOncogene, 24
T. Reya, S. Morrison, M. Clarke, I. Weissman (2001)
Stem cells, cancer, and cancer stem cellsNature, 414
S. Albelda, S. Mette, D. Elder, R. Stewart, L. Damjanovich, M. Herlyn, C. Buck (1990)
Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression.Cancer research, 50 20
V. Vallacchi, Maria Daniotti, F. Ratti, Delia Stasi, Paola Deho, A. Filippo, G. Tragni, A. Balsari, A. Carbone, L. Rivoltini, G. Parmiani, N. Lazar, B. Perbal, M. Rodolfo (2008)
CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.Cancer research, 68 3
Hema Rangaswami, Anuradha Bulbule, G. Kundu (2006)
Osteopontin: role in cell signaling and cancer progression.Trends in cell biology, 16 2
K. Ilunga, R. Nishiura, Hiroyasu Inada, A. El-Karef, K. Imanaka-Yoshida, T. Sakakura, Toshimichi Yoshida (2004)
Co‐stimulation of human breast cancer cells with transforming growth factor‐β and tenascin‐C enhances matrix metalloproteinase‐9 expression and cancer cell invasionInternational Journal of Experimental Pathology, 85
WH Clark (1991)
Tumour progression and the nature of cancerBr J Cancer, 64
M. Wicha, Suling Liu, G. Dontu (2006)
Cancer stem cells: an old idea--a paradigm shift.Cancer research, 66 4
E. Garçion, Aida Halilagic, A. Faissner, C. ffrench-Constant (2004)
Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C, 131
B. Perbal (1999)
Nuclear localisation of NOVH protein: a potential role for NOV in the regulation of gene expression.Molecular Pathology, 52
G. Orend, R. Chiquet‐Ehrismann (2006)
Tenascin-C induced signaling in cancer.Cancer letters, 244 2
A. Desmoulière, C. Guyot, G. Gabbiani (2004)
The stroma reaction myofibroblast: a key player in the control of tumor cell behavior.The International journal of developmental biology, 48 5-6
S. Sarkar, R. Nuttall, Shuhong Liu, D. Edwards, V. Yong (2006)
Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12.Cancer research, 66 24
O. Wever, Q. Nguyen, L. Hoorde, M. Bracke, E. Bruyneel, C. Gespach, M. Mareel (2004)
Tenascin‐C and SF/HGF produced by myofibroblasts in vitro provide convergent proinvasive signals to human colon cancer cells through RhoA and RacThe FASEB Journal, 18
M. Iruela-Arispe, T. Lane, D. Redmond, M. Reilly, R. Bolender, T. Kavanagh, E. Sage (1995)
Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo.Molecular biology of the cell, 6 3
Alexei Likhachev, Dzamal Beniashvili, Vladimir Bykov, Pavel Dikun, M. Tyndyk, I. Savochkina, Vladimir Yermilov, M. Zabezhinski (1992)
Biomarkers for individual susceptibility to carcinogenic agents: excretion and carcinogenic risk of benzo[a]pyrene metabolites.Environmental Health Perspectives, 98
B. Perbal, D. Brigstock, L. Lau (2003)
Report on the second international workshop on the CCN family of genesMolecular Pathology, 56
D. Fang, Thiennga Nguyen, K. Leishear, R. Finko, A. Kulp, S. Hotz, P. Belle, Xiaowei Xu, D. Elder, M. Herlyn (2005)
A tumorigenic subpopulation with stem cell properties in melanomas.Cancer research, 65 20
W. Hindermann, A. Berndt, L. Borsi, Xinmei Luo, P. Hyckel, D. Katenkamp, H. Kosmehl (1999)
Synthesis and protein distribution of the unspliced large tenascin‐C isoform in oral squamous cell carcinomaThe Journal of Pathology, 189
Danny Welch, Toshiyuki Sakamaki, R. Pioquinto, T. Leonard, S. Goldberg, Qiufang Hon, Raymond Erikson, M. Rieber, M. Rieber, Deana Hicks, Joseph Bonventre, Alessandro Alessandrini (2000)
Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells.Cancer research, 60 6
C. Fu, J. Bechberger, M. Ozog, B. Perbal, C. Naus (2004)
CCN3 (NOV) Interacts with Connexin43 in C6 Glioma CellsJournal of Biological Chemistry, 279
K. Moore, I. Lemischka (2006)
Stem Cells and Their NichesScience, 311
M. Maillard, B. Cadot, R. Ball, K. Sethia, D. Edwards, B. Perbal, R. Tatoud (2001)
Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissuesMolecular Pathology, 54
C. Schultz, N. Lemke, S. Ge, W. Golembieski, S. Rempel (2002)
Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo.Cancer research, 62 21
N. Gupta, H. Wang, T. McLeod, C. Naus, S. Kyurkchiev, S. Advani, J. Yu, B. Perbal, R. Weichselbaum (2001)
Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV)Molecular Pathology, 54
D. Denhardt, M. Noda, A. O’Regan, D. Pavlin, J. Berman (2001)
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.The Journal of clinical investigation, 107 9
Michael Kiefer, Diane Bauer, Philip Barr (1989)
The cDNA and derived amino acid sequence for human osteopontin.Nucleic acids research, 17 8
A. Breslow (1970)
Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 172
S. Krengel, Imke Stark, C. Geuchen, Bettina Knoppe, G. Scheel, P. Schlenke, A. Gebert, L. Wünsch, J. Brinckmann, M. Tronnier (2005)
Selective down‐regulation of the α6‐integrin subunit in melanocytes by UVB lightExperimental Dermatology, 14
M. Chellaiah, C. Fitzgerald, E. Filardo, D. Cheresh, K. Hruska (1996)
Osteopontin activation of c-src in human melanoma cells requires the cytoplasmic domain of the integrin alpha v-subunit.Endocrinology, 137 6
M. Hsu, F. Meier, M. Nesbit, J. Hsu, P. Belle, D. Elder, M. Herlyn (2000)
E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.The American journal of pathology, 156 5
L. Derr, R. Chiquet‐Ehrismann, R. Gandour-Edwards, J. Spence, R. Tucker (1997)
The expression of tenascin-C with the AD1 variable repeat in embryonic tissues, cell lines and tumors in various vertebrate species.Differentiation; research in biological diversity, 62 2
Matricellular proteins are modulators of cell-matrix interactions and cellular functions. The group includes thrombospondin, osteopontin, osteonectin/SPARC, tenascin, disintegrins, galectins and CCN proteins. The production of matricellular proteins such as osteopontin, SPARC or tenascin is highly upregulated in melanoma and other tumors but little is known about their functions in tumor growth, survival, and metastasis. The distribution pattern of CCN3 differs from most other matricellular proteins, such that it is produced abundantly by normal melanocytes, but is not significantly expressed in melanoma cells. CCN3 is known to inhibit melanocyte proliferation and stimulate adhesion to collagen type IV, the main component of the basement membrane. CCN3 has a unique role in securing adhesion of melanocytes to the basement membrane distinct from other melanoma-produced matricellular proteins which act as de-adhesive molecules and antagonists of focal adhesion. Qualitative and quantitative changes in matricellular protein expression contribute to melanoma progression similar to the E-cadherin to N-cadherin class switch, allowing melanoma cells to escape from keratinocyte control.
Cancer Microenvironment – Springer Journals
Published: Mar 26, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.